Nirsevimab-alip as a New Option to Prevent Respiratory Syncytial Virus
Target Audience: Pharmacist, Pharmacy Tech
Course Overview
Respiratory syncytial virus is a respiratory virus that typically presents with mild, cold-like symptoms; however, some population groups are at increased risk of developing severe symptoms or dying from it. Children under five years of age are particularly at risk of severe illness, hospitalization, or death, driving the need for better preventive approaches for this age group. Nirsevimab-alip has recently been approved to prevent severe respiratory syncytial virus infection in infants and children under 24 months of age. This vaccine may be used as part of a prevention plan during the viral season. This course reviews the prevalence and risk factors for the virus, its prevention (including immunization with nirsevimab-alip), symptom management, and the impact that pharmacists and pharmacy staff may have in caring for pediatric patients at risk of severe respiratory syncytial virus symptoms.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Identify individuals at high risk of severe respiratory syncytial virus (RSV) disease
- Discuss strategies to prevent RSV
- Identify individuals who are indicated to receive nirsevimab-alip
- Outline the dosing and administration guidelines for nirsevimab-alip
Faculty
- Introduction
- Prevalence of Respiratory Syncytial Virus
- Risk Factors for RSV
- Transmission of RSV
- RSV Symptoms and Their Management
- Prevention of RSV
- Nirsevimab-alip
- Indications
- Dosing and Administration
- Mechanism of Action
- Storage and Handling
- Contraindications, Warnings, and Precautions
- Adverse Reactions
- Drug Interactions
- Specific Populations
- Overdosage
- Clinical Studies
- Interdisciplinary Approach and Collaboration
- Summary
- Disclosures
From July 14, 2026 through January 8, 2027, participants must:
- Read the "learning objectives" and "author and planning team disclosures"
- Study the section entitled "educational activity"
- Complete the Course Test and Evaluation form. The Course Test will be graded automatically. Following successful completion of the Course Test with a score of 70% or higher, a statement of participation will be made available immediately. (No partial credit will be given.)
Credit for this course will be automatically uploaded to CPE Monitor®.
Faculty Planner Disclosure
The following individuals were involved in planning, developing, and/or authoring this activity: Kristina (Tia) Neu, RN; and Pamela Sardo, PharmD, BS. None of the individuals involved in developing this activity has a conflict of interest or financial relationships related to the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.
Unlabeled Use Disclosure
The information provided in this course is general in nature, and it is designed solely to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant's professional practice, including but not limited to patient assessment, diagnosis, treatment, and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals must consult their employer, healthcare facility, hospital, or other organization for guidelines, protocols, and procedures to follow. The information provided in this course does not replace those guidelines, protocols, and procedures, but is for academic purposes only, and this course's limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses is constantly changing. Any person taking this course understands that such a person must make an independent review of medication information before any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only, and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course or course material.
Please ensure the device you plan to use meets these requirements:
- Operating System: Windows 7, 8, 10, or 11 / Mac OS X 10.9 or later / iOS / Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
Accreditation
In support of improving patient care, RxCE.com is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PTCB Recognition
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".